- JP-listed companies
- Japan Tissue Engineering Co., Ltd.
- Income statement
Japan Tissue Engineering Co., Ltd. (7774) Income statement
Market cap
¥23.5B
P/E ratio
235x
Develops and manufactures regenerative medicine products that restore tissue function by culturing patients' own cells for transplantation.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Revenue | 474 | 564 | 1,008 | 1,321 | 1,431 | 2,135 | 2,272 | 2,358 | 2,310 | 2,258 | 2,103 | 2,032 | 2,514 | 2,455 | 2,183 |
| Revenue growth (%) | - | ||||||||||||||
| Cost of revenue | - | - | - | 794 | 852 | 911 | 918 | 1,073 | 1,122 | 1,101 | 848 | 896 | 824 | 944 | 915 |
| Gross profit | - | - | - | 528 | 579 | 1,224 | 1,354 | 1,285 | 1,188 | 1,157 | 1,255 | 1,137 | 1,691 | 1,511 | 1,267 |
| Gross margin (%) | - | - | - | ||||||||||||
| Operating margin (%) | - | - | - | ||||||||||||
| Operating expenses | - | - | - | 1,216 | 1,302 | 912 | 1,142 | 1,634 | 1,423 | 1,624 | 1,754 | 1,865 | 1,546 | 1,750 | 1,817 |
| Operating income | - | - | - | -688 | -723 | 312 | 212 | -350 | -235 | -467 | -498 | -728 | 145 | -238 | -549 |
| Income before tax | -1,093 | -1,074 | -824 | -687 | -678 | 310 | 213 | -340 | -230 | -463 | -494 | -725 | 147 | -234 | -537 |
| Pretax margin (%) | -230.7 | -190.5 | -81.7 | -52 | -47.4 | 14.5 | 9.4 | -14.4 | -9.9 | -20.5 | -23.5 | -35.7 | 5.8 | -9.5 | -24.6 |
| Provision for income taxes | - | - | - | 4 | 4 | 34 | -15 | -6 | 57 | 4 | 4 | 4 | 4 | 21 | 4 |
| Effective tax rate (%) | - | - | - | ||||||||||||
| Net income | -1,096 | -1,078 | -828 | -691 | -682 | 276 | 228 | -333 | -287 | -467 | -498 | -729 | 143 | -255 | -734 |
| Earnings per share | -29.98 | -29.47 | -22.54 | -18.21 | -16.79 | 6.81 | 5.61 | -8.21 | -7.07 | -11.49 | -12.26 | -17.96 | 3.53 | -6.29 | -18.09 |
| Diluted EPS | - | - | - | - | - | 6.81 | - | - | - | - | - | - | - | - | - |
| Dividend per share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |